Is Diltiazem effective for treating lichen sclerosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Diltiazem is not recommended as a first-line treatment for lichen sclerosus, and instead, a potent topical corticosteroid, such as clobetasol propionate 0.05% ointment, should be used as the primary treatment. The standard treatment for lichen sclerosus is based on guidelines from reputable sources, including the British Association of Dermatologists 1. For lichen sclerosus, the recommended regimen is:

  • Apply clobetasol propionate 0.05% ointment once daily for 4 weeks
  • Then reduce to every other day for 4 weeks
  • Finally, maintain with twice weekly applications long-term Diltiazem, a calcium channel blocker, has been studied for lichen sclerosus in limited cases, primarily for its potential to improve blood flow and reduce inflammation. However, its efficacy is not well-established, and it should only be considered as an alternative or adjunct therapy under specialist guidance 1. If considering diltiazem, it would typically be used as a 2% topical preparation, applied twice daily. However, patients should be aware that this is an off-label use and may not be as effective as standard corticosteroid treatment. The primary goal in treating lichen sclerosus is to control symptoms, prevent scarring, and reduce the risk of malignant transformation, and topical corticosteroids remain the most effective way to achieve these goals based on current evidence 1.

From the Research

Treatment Options for Lichen Sclerosus

  • The primary treatment for lichen sclerosus is topical high potency corticosteroids, as recommended by 2 and 3.
  • Second- and third-line treatments include topical calcineurin inhibitors and topical retinoids, respectively, as suggested by 2 and 4.
  • Surgical treatment is considered for male genital lichen sclerosus with persistent phimosis not responsive to medical treatment, as stated by 2 and 3.

Effectiveness of Diltiazem for Lichen Sclerosus

  • There is no mention of Diltiazem as a treatment option for lichen sclerosus in the provided studies 2, 3, 4, 5, 6.
  • The studies focus on the effectiveness of topical corticosteroids, calcineurin inhibitors, and other treatments, but do not discuss Diltiazem as a potential treatment for lichen sclerosus.

Alternative Treatment Options

  • Photodynamic therapy, as discussed in 5, may be a novel option for the treatment of anogenital lichen sclerosus.
  • Other alternative treatments, such as avocado and soya beans extracts, may be considered for mild cases, as reported by 5.
  • Systemic therapies, including corticosteroids, retinoids, and biologics, may be considered for cutaneous lichen planus, as reviewed by 6, but their effectiveness for lichen sclerosus is not discussed.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

EuroGuiderm guideline on lichen sclerosus-Treatment of lichen sclerosus.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2024

Research

New therapeutic approaches in the treatment of anogenital lichen sclerosus: does photodynamic therapy represent a novel option?

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2017

Research

Treatment of cutaneous lichen planus (part 2): a review of systemic therapies.

The Journal of dermatological treatment, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.